Radiation therapy in retroperitoneal sarcoma management

Surgery is potentially curative for primary non‐metastatic retroperitoneal soft tissue sarcomas (RPS), although patients remain at risk for local recurrence. To reduce this risk, the addition of radiotherapy to radical surgery may be considered. Nevertheless, level I evidence to support radiotherapy...

Full description

Saved in:
Bibliographic Details
Published inJournal of surgical oncology Vol. 117; no. 1; pp. 93 - 98
Main Authors Haas, Rick L., Baldini, Elizabeth H., Chung, Peter W., van Coevorden, Frits, DeLaney, Thomas F.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.01.2018
Subjects
brachytherapy
Cancer surgery
Gastric cancer
proton beam therapy
Radiation therapy
radiotherapy
retroperitoneal sarcoma
Sarcoma
radiotherapy
retroperitoneal sarcoma
brachytherapy
proton beam therapy
Online AccessGet full text

Cover

More Information
Summary:Surgery is potentially curative for primary non‐metastatic retroperitoneal soft tissue sarcomas (RPS), although patients remain at risk for local recurrence. To reduce this risk, the addition of radiotherapy to radical surgery may be considered. Nevertheless, level I evidence to support radiotherapy is currently lacking. The results from the EORTC‐STBSG 62092‐22092 studying this question are awaited. This manuscript addresses issues to consider when radiation‐oncologists engage in a multidisciplinary treatment approach for RPS patients, including radiotherapy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.24892